Selected article for: "disease spread and herd immunity"

Author: Metzger, Vincent T.; Lloyd-Smith, James O.; Weinberger, Leor S.
Title: Autonomous Targeting of Infectious Superspreaders Using Engineered Transmissible Therapies
  • Document date: 2011_3_17
  • ID: 0gt21051_2
    Snippet: Targeting these superspreader subpopulations for therapeutic or preventive measures would tremendously increase the efficacy of disease control [3, 4] , while failure to target high-risk groups weakens efforts to achieve 'herd immunity' by vaccination and severely limits the ability to reduce disease at the population level [12] . Unfortunately, identifying these crucial high-risk populations requires in-depth knowledge of the social or sexual ne.....
    Document: Targeting these superspreader subpopulations for therapeutic or preventive measures would tremendously increase the efficacy of disease control [3, 4] , while failure to target high-risk groups weakens efforts to achieve 'herd immunity' by vaccination and severely limits the ability to reduce disease at the population level [12] . Unfortunately, identifying these crucial high-risk populations requires in-depth knowledge of the social or sexual networks that underlie disease spread, which is rarely attainable [13] , as well as knowledge of as-yet unknown biological correlates of risk. Further aggravating the problem of targeting superspreaders are: (i) nonhealthseeking behaviors in the key populations, such as injection drug users (IDUs); and (ii) self-concealment motivated by social stigmas and criminal barriers in high-risk individuals, such as IDUs, men who have sex with men, people with extra-marital sexual partners, and commercial sex workers and their clients.

    Search related documents:
    Co phrase search for related documents
    • commercial sex and high risk: 1, 2, 3
    • commercial sex and high risk group: 1
    • crucial high risk population and high risk: 1, 2
    • crucial high risk population and high risk group: 1
    • depth knowledge and disease control: 1
    • depth knowledge and disease reduce: 1
    • depth knowledge and high risk: 1
    • depth knowledge and high risk group: 1
    • disease control and herd immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease control and herd immunity achieve: 1, 2, 3
    • disease control and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease control and high risk group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • disease reduce and herd immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • disease reduce and herd immunity achieve: 1, 2
    • disease reduce and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease reduce and high risk group: 1, 2, 3
    • drug user and high risk: 1
    • herd immunity and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • herd immunity and high risk group: 1, 2, 3, 4, 5, 6, 7